Dashboard
Manage Tickers

COR Cencora, Inc.

NYSE www.cencora.com


$ 320.32 $ 0.00 (0 %)    

Friday, 17-Oct-2025 04:32:34 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 592.17 $ 0.00 (0 %)
DIA $ 455.71 $ 0.00 (0 %)
SPY $ 653.35 $ 0.00 (0 %)
TLT $ 91.46 $ 0.00 (0 %)
GLD $ 399.40 $ 0.00 (0 %)
$ 319.4
$ 319.65
$ 304.68 x 1
$ 329.00 x 2
-- - --
$ 222.57 - $ 321.87
1,399,196
na
61.92B
$ 0.51
$ 32.64
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 02-05-2025 12-31-2024 10-Q
4 11-26-2024 09-30-2024 10-K
5 07-31-2024 06-30-2024 10-Q
6 05-01-2024 03-31-2024 10-Q
7 01-31-2024 12-31-2023 10-Q
8 11-21-2023 09-30-2023 10-K
9 08-02-2023 06-30-2023 10-Q
10 05-02-2023 03-31-2023 10-Q
11 02-01-2023 12-31-2022 10-Q
12 11-22-2022 09-30-2022 10-K
13 08-03-2022 06-30-2022 10-Q
14 05-04-2022 03-31-2022 10-Q
15 02-02-2022 12-31-2021 10-Q
16 11-23-2021 09-30-2021 10-K
17 08-04-2021 06-30-2021 10-Q
18 05-05-2021 03-31-2021 10-Q
19 02-04-2021 12-31-2020 10-Q
20 11-19-2020 09-30-2020 10-K
21 08-05-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 01-30-2020 12-31-2019 10-Q
24 11-19-2019 09-30-2019 10-K
25 08-01-2019 06-30-2019 10-Q
26 05-02-2019 03-31-2019 10-Q
27 01-31-2019 12-31-2018 10-Q
28 11-20-2018 09-30-2018 10-K
29 08-02-2018 06-30-2018 10-Q
30 05-02-2018 03-31-2018 10-Q
31 02-06-2018 12-31-2017 10-Q
32 11-21-2017 09-30-2017 10-K
33 08-03-2017 06-30-2017 10-Q
34 05-04-2017 03-31-2017 10-Q
35 01-31-2017 12-31-2016 10-Q
36 11-22-2016 09-30-2016 10-K
37 08-02-2016 06-30-2016 10-Q
38 05-05-2016 03-31-2016 10-Q
39 02-04-2016 12-31-2015 10-Q
40 11-24-2015 09-30-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

mizuho-maintains-outperform-on-cencora-raises-price-target-to-334
Mizuho Maintains Outperform on Cencora, Ra...
10/16/2025 13:12:54

Mizuho analyst Steven Valiquette maintains Cencora (NYSE:COR) with a Outperform and raises the price target from $316 to $334.

cencoras-intrinsiq-expands-oncology-biomarker-data-and-therapeutic-insights-to-advance-precision-medicine-and-support-biopharmaceutical-innovation
Cencora's IntrinsiQ Expands Oncology Bioma...
10/16/2025 13:07:29

Biomarker data, enhanced therapeutic data and insights will enable biopharmaceutical innovation and physician support through i...

1000-invested-in-cencora-5-years-ago-would-be-worth-this-much-today
$1000 Invested In Cencora 5 Years Ago Woul...
10/06/2025 16:30:39

what-does-the-market-think-about-cencora
What Does the Market Think About Cencora?
09/23/2025 16:02:39

1000-invested-in-cencora-10-years-ago-would-be-worth-this-much-today
$1000 Invested In Cencora 10 Years Ago Wou...
09/16/2025 22:45:22

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/04/2025 21:13:45

Core News & Articles
U.S. Health Secretary Kennedy On Pharmacy ...
09/04/2025 15:21:00

https://www.youtube.com/watch?v=2KW1mVChh-c&feature=youtu.be

if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-this-much-today
If You Invested $1000 In This Stock 10 Yea...
08/29/2025 23:45:17

cencora-appoints-mark-durcan-as-chairman-of-the-board-effective-october-1-2025-succeeding-steven-collis
Cencora Appoints Mark Durcan As Chairman O...
08/27/2025 20:18:54

looking-into-cencoras-recent-short-interest
Looking Into Cencora's Recent Short Interest
08/26/2025 17:01:06

heres-how-much-100-invested-in-cencora-5-years-ago-would-be-worth-today
Here's How Much $100 Invested In Cencora 5...
08/18/2025 20:00:54

analyst-expectations-for-cencoras-future
Analyst Expectations For Cencora's Future
08/13/2025 13:00:24

wells-fargo-maintains-overweight-on-cencora-raises-price-target-to-354
Wells Fargo Maintains Overweight on Cencor...
08/13/2025 12:40:04

Wells Fargo analyst Stephen Baxter maintains Cencora (NYSE:COR) with a Overweight and raises the price target from $337 to $...

wall-street-recovers-apple-rallies-6-on-100-billion-gov-manufacturing-investment-whats-moving-markets-wednesday
Wall Street Recovers, Apple Rallies 6% On ...
08/06/2025 17:43:34

U.S. stocks rebounded sharply on Wednesday, fully erasing last Friday's losses, as upbeat corporate earnings and renewed in...

cencora-says-famed-glp-1-class-products-drive-growth-boosts-profit-outlook
Cencora Says Famed GLP-1 Class Products Dr...
08/06/2025 17:13:54

Cencora reports Q3 sales of $80.66 billion and EPS of $4.00, both above estimates, driven by GLP-1 and specialty drug demand in...

during-conf-call-cencora-reportedly-exec-says-too-early-to-assess-impact-of-mfn-and-other-policy-changes-co-engaged-with-policymakers-to-ensure-access-to-community-providers-is-maintained-no-material-impacts-from-tariffs-identified-on-business-not-changing-sourcing-practices-based-on-tariffs-and-has-confidence-in-supply-chain-monitoring-differences-in-brand-vs-generic-supply-chains-for-risk-of-shortages-and-patient-access-disruptions
During Conf Call, Cencora Reportedly Exec ...
08/06/2025 13:23:35

cencora-raises-fy2025-adj-eps-guidance-from-1570-1595-to-1585-1600-vs-1581-est-updates-fy2025-sales-guidance-from-317368b-323245b-to-approximately-320306b-vs-321637b-est
Cencora Raises FY2025 Adj EPS Guidance fro...
08/06/2025 10:37:51

Fiscal Year 2025 ExpectationsCencora is now updating its fiscal year 2025 financial guidance primarily to reflect stronger earn...

cencora-q3-2025-adj-eps-400-beats-382-estimate-sales-80664b-beat-80354b-estimate
Cencora Q3 2025 Adj. EPS $4.00 Beats $3.82...
08/06/2025 10:31:29

Core News & Articles
Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

1000-invested-in-this-stock-10-years-ago-would-be-worth-this-much-today
$1000 Invested In This Stock 10 Years Ago ...
08/04/2025 14:30:25

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION